M & As this week: NantCell, Shanghai No1 Pharmacy

NantCell has signed a definitive agreement to acquire Altor BioScience for a purchase consideration of approximately $290m.

Source: Drug Development Technology - June 29, 2017 Category: Pharmaceuticals Source Type: news